Previous 10 | Next 10 |
home / stock / mrvl / mrvl articles
Steve Cohen's Point72 Asset Management is set to launch a new hedge fund with a focus on artificial intelligence, aiming to raise approximatel...
Broadcom Inc. (NASDAQ:AVGO) shares are trading higher Monday afternoon. The significant rise follows the company’s second-quarter financial ...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 20 years by 1.11% on an annualized basis producing an average annual return of...
Have you evaluated the performance of Marvell Technology's (NASDAQ: MRVL) international operations during the quarter that concluded in April 2...
Shares of SentinelOne, Inc. (NYSE:S) shares fell sharply during Friday's session after the company posted mixed first-quarter results. Sentine...
Stocks look set to end May on a positive note, even as index futures pointed to a negative opening on Friday. But sentiment could reverse if import...
U.S. stock futures were mostly lower this morning, with the Nasdaq futures falling around 70 points on Friday. Shares of Marvell Technology, Inc. (...
Marvell Technology, Inc. (NASDAQ:MRVL) reported its first-quarter financial results after the bell Thursday. Here's a look at the highlights f...
U.S. stocks are likely to remain weak on Thursday, major index futures indicated, as lower bond yields stayed elevated and mixed earnings dampened ...
News, Short Squeeze, Breakout and More Instantly...
Marvell Technology Inc. Company Name:
MRVL Stock Symbol:
NASDAQ Market:
Marvell Technology Inc. Website:
Calgary, Alberta--(Newsfile Corp. - July 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), is pleased to report that, further to its press releases of May 16, 2024 and June 21, 2024, it has ...
2024-07-15 18:00:00 ET Broadcom (NASDAQ: AVGO) and Marvell Technology (NASDAQ: MRVL) usually don't attract as much attention as higher-growth chipmakers like Nvidia (NASDAQ: NVDA) . But like Nvidia, both diversified chip specialists are benefiting from the rapid ...
Calgary, Alberta--(Newsfile Corp. - July 9, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to highlight the recently published paper "Neuronal A2A receptor exacerbate...